Lumosa Therapeutics Co., Ltd.

This study tested a single dose of the experimental drug LT3001 in 24 adults who had an acute ischemic stroke (a stroke caused by a blood clot). The main goal was to see if the drug is safe and does not cause dangerous bleeding in the brain. Participants received either LT3001 or…

This study tested a new drug, LT3001, in 89 adults who had an acute ischemic stroke (a stroke caused by a blood clot). The goal was to see if the drug is safe and helps recovery when given within 24 hours of symptoms. Participants received either the drug or a placebo, and resear…

This study tested a single injection of a long-acting painkiller (SDE) to manage pain after hemorrhoid removal surgery. 221 adults received either the drug or a placebo, and their pain levels were tracked for 48 hours. The goal was to see if the injection safely reduces pain and …

This early-stage study tested the safety of a new drug called LT3001, which is being developed for acute ischemic stroke. Researchers gave the drug to 65 healthy adults to see how it interacts with common medications like aspirin and blood thinners. The goal was to check for side…